Contributing factors to variability in biological indicator performance data

JE Moldenhauer - PDA journal of pharmaceutical science and …, 1999 - journal.pda.org
In the past few years, there has been a change in emphasis by regulatory and compendial
requirements to require that pharmaceutical manufacturers verify the accuracy of the thermal …

Microbiological Test Data—Assuring Data Integrity

EC Tidswell, T Sandle - PDA Journal of Pharmaceutical Science …, 2018 - journal.pda.org
Marketed drugs and devices possess specifications including critical microbiological quality
attributes purposed to assure efficacy and patient safety. These attributes are legislated …

Quality considerations in the establishment of specifications for pharmaceuticals

D Sandell, T Tougas - Statistics in Biopharmaceutical Research, 2012 - Taylor & Francis
The quality of a commercial pharmaceutical product is set by a well-designed, understood,
and executed manufacturing process using high-quality raw materials. In addition, this built …

[PDF][PDF] A comparison of process validation standards

J Boatman - Pharmaceutical Engineering, 2013 - ispe.gr.jp
Life science firms in the US are currently subject to two different process validation
standards: the GHTF's Process Validation Guidance and the FDA's Process Validation …

The harmonization of the microbial limits tests.

S Sutton - Pharmaceutical Technology, 2006 - go.gale.com
The US Pharmacopeia (USP), the Japanese Pharmacopoeia, and the European
Pharmacopoeia" Microbial Limits Tests" are in the final stages of harmonization. The …

[PDF][PDF] Biological indicators in the pharmaceutical and medical device industry

IJ Pflug, TE Odlaug - Journal of Parenteral Science and Technology, 1986 - drpflug.com
In the first part of this article Bis are closely examined regarding their constituents, attributes,
and problems. The idea is developed that Bis are accurate measuring units when properly …

[PDF][PDF] results of Evaluation of the lKB 2277 Calorimeter for stability testing of Pharmaceuticals

MJ Pikal - LKB Application Note 335, 1983 - tainstruments.com
BaCKGrounD At the preformulation stage of product development, estimates of chemical
and/or physical stability are normally derived from accelerated stability tests and occasional …

[BOOK][B] Validation standard operating procedures: A step by step guide for achieving compliance in the pharmaceutical, medical device, and biotech industries

SI Haider - 2006 - taylorfrancis.com
Spanning every critical element of validation for any pharmaceutical, diagnostic, medical
device or equipment, and biotech product, this Second Edition guides readers through each …

A biological safety program prospectus based on the collection of 10 years of key performance indicator data

RJ Emery, RK Gamble, BJ Brown - Applied Biosafety, 2012 - liebertpub.com
In fiscal year 2000, the University of Texas Health Science Center at Houston (UTHSC-H)
Biological Safety Program began systematically assembling data on a monthly basis that …

Determining the capability of a drug product to be terminally sterilized: A case study involving a heat-sensitive, oxygen-sensitive drug product

MR Duncan, P Wang… - Pharmaceutical …, 1998 - Taylor & Francis
ABSTRACT A decision scheme for determining the capability of a finished product dosage
form to be terminally sterilized was presented and followed for a heat-sensitive, oxygen …